NYSE: CBZCbiz Inc Stock
$77.46-1.23 (-1.56%)
Updated Apr 17, 2025
CBZ Price
$77.46
Fair Value Price
N/A
Market Cap
$4.16B
52 Week Low
$62.66
52 Week High
$90.13
P/E
99.31x
P/B
2.34x
P/S
2.36x
PEG
0.34x
Dividend Yield
N/A
Revenue
$1.81B
Earnings
$41.04M
Gross Margin
10.1%
Operating Margin
5.08%
Profit Margin
2.3%
Debt to Equity
1.51
Operating Cash Flow
$124M
Beta
0.79
Next Earnings
Apr 23, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CBZ Overview
CBIZ, Inc. provides financial, insurance, and advisory services to companies in the agribusiness, construction, health care, oil and gas, real estate, and retail sectors, as well as governmens. The company was incorporated in 1987 and is headquartered in Cleveland, OH.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CBZ's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Business Service
Industry Rating
B
CBZ
Ranked#16 of 33
Ranked#16 of 33
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $6.94 | A | |
| $5.19 | A | |
| $71.97 | A |
Be the first to know about important CBZ news, forecast changes, insider trades & much more!
CBZ News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CBZ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CBZ ($77.46) is trading below its intrinsic value of $84.21, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CBZ is poor value based on its earnings relative to its share price (99.31x), compared to the US market average (27.98x)
P/E vs Market Valuation
CBZ is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more CBZ due diligence checks available for Premium users.
Valuation
CBZ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
99.31x
Industry
37.74x
Market
27.98x
CBZ is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CBZ is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CBZ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.34x
Industry
5.08x
CBZ is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CBZ price to earnings growth (PEG)
For valuing profitable companies with growth potential
CBZ is good value based... subscribe to Premium to read more.
PEG Value Valuation
CBZ's financial health
Profit margin
Revenue
$460.3M
Net Income
-$90.7M
Profit Margin
-19.7%
CBZ's Earnings (EBIT) of $92.19M... subscribe to Premium to read more.
Interest Coverage Financials
CBZ's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.5B
Liabilities
$2.7B
Debt to equity
1.51
CBZ's short-term assets ($835.73M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CBZ's long-term liabilities ($1.99B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CBZ's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CBZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$55.5M
Investing
-$1.1B
Financing
$1.1B
CBZ's operating cash flow ($123.69M)... subscribe to Premium to read more.
Debt Coverage Financials
CBZ vs Specialty Business Service Stocks
Cbiz Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.